"10.1371_journal.pone.0074063","plos one","2013-09-16T00:00:00Z","Bjørn A Nexø; Bettina Hansen; Kari K Nissen; Lisa Gundestrup; Thorkild Terkelsen; Palle Villesen; Shervin Bahrami; Thor Petersen; Finn S Pedersen; Magdalena J Laska","Department of Biomedicine, Aarhus University, Aarhus C, Denmark; Bioinformatics Research Centre, Aarhus University, Aarhus C, Denmark; SKAUvaccines, Incuba Science Park, Aarhus C, Denmark; Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark; Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark","Conceived and designed the experiments: BAN KKN MJL. Performed the experiments: BH LG TT. Analyzed the data: BAN SB FSP MJL TP PV. Contributed reagents/materials/analysis tools: TP. Wrote the manuscript: BAN KKN FSP SB.","The author Shervin Bahrami is CEO for the company SKAUvaccines plc, and works professionally with the development of vaccines against viral diseases. Consequently, he has no professional interest in the role of HERVs, neither in the form of patents, products or restriction of HERVs. He simply participates as a knowledgeable retrovirologist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Bjørn A Nexø","BAN",10,TRUE,3,3,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
